Autoscribe Informatics Appoints Distributor for France, Italy & Switzerland
News Jun 23, 2016
John Boother, President at Autoscribe Informatics said: “Following on from our recent successes in the USA, we are also keen to expand our penetration into European markets. With three offices and a staff boasting qualified scientists from a number of disciplines, Ritme has a field-based and in-house team of native speakers that work closely with customers both before and after product purchase, which exactly mirrors our own approach. Ritme’s well-established consulting services will facilitate and drive successful LIMS projects.”
Ritme CEO, Thierry Berton, commented: “Matrix Gemini LIMS is an important extension to our scientific software portfolio allowing our customers to efficiently manage their laboratories. The flexibility of Autoscribe Informatics LIMS solution allows either Ritme, or our customers, to configure a solution that meets the exact needs of each laboratory. The configuration tools provide easy adaption of desktop and web based applications without the use of any software scripts or coding. It makes it the perfect choice for laboratories that need to adapt their LIMS as the working practices in the laboratory change. In addition, the ability to run fully tailored state-of-the-art LIMS offline is a critical selling point for many labs with high data protection policies.”
Big Data Study Targets Genomic Dark Matter from Ocean Floor to Gut FloraNews
An international team led by computational biologist Fran Supek at IRB Barcelona develop a machine learning method to predict unknown gene functions of microbes.The system examines and compares ‘big data’ available on the metagenomes of human and environmental microbiomes.READ MORE
Machine Learning Model Provides Early Dementia DiagnosisNews
Improving dementia care through increased and timely diagnosis is an NHS priority, yet around half of those living with dementia live with the condition unaware. Now a new machine-learning model that scans routinely collected NHS data has shown promising signs of being able to predict undiagnosed dementia in primary care.